iGEM Thessaly 2020: Amalthea phase I


Amalthea is a complete, personalized, modular platform, which provides diagnosis, evaluation of the gut flora, and treatment of IBDs. A non-invasive encapsulated detection module, consisting of a genetically engineered bacteria-based system and an electronic system, will identify metabolite deficiencies directly correlated to IBDs, that may lead to malnutrition. Exploiting a bio-electronic interface to enable real-time monitoring on the patient’s smartphone. Based on this personalized data, a biosynthetic module will respond with selective production of the missing metabolites, thus eliminating that nutritional deficit and relieving the patient of the symptoms. Our product is designed according to healthcare experts and international standards, to ensure bio-safety.

You can learn more about Amalthea 2020 here

Amalthea's 2020 Poster


Swipe to meet the team

Foteini Papadaki
Project Leader

Magdalini Koroxenidou
Wet Lab

Asteria Tsapadikou
Wet Lab

Venetios Michelioudakis
Wet Lab

    Ifigenia Daskalaki
   Graphic Designer

Emmanouil Stylianakis
Wet Lab

Anastasios Messis
Dry Lab

Vasilis Stergiou
Dry Lab

Georgios Mouchtaridis
Wiki Team

Lemonia Apocha
Human Practices

Our medals

Gold Medal